Company Name : Beardsworth Consulting Group Inc.

Company Address : 70 Church St.  , Flemington, NJ,  United States, 

Donna Beardsworth Biography :

Donna E. Beardsworth, MA, Executive Vice President and Chief Delivery Officer, brings over 24 years of clinical research experience including 'hands-on' in-clinic responsibilities and clinical project and personnel management to her position. She has worked at the investigative site level, the sponsor level, and at the CRO level in all aspects of clinical drug development processes. Her experience in clinical research affords an incomparable vantage point from which to assess and develop clinical research practices. Donna is uniquely qualified to bring a unity of vision to the conduct and management of outsourced clinical trial functions. Donna heads both the Executive and the Senior Management Teams at Beardsworth and is the Chair of the Advisory Board. Donna was named Entrepreneur of the Year in 2002 by the Hunterdon County Chamber of Commerce and is a past President of the NNJ-ACRP Chapter where she currently serves as a trustee.

Donna Beardsworth Colleagues :

• Michael O'Brien :   Pres., CEO

• Vincent Dibianca :   Principal, Exec. Management Team, Member - Advisory Board

• Steven Trigilio :   CTO

• Art Gertel :   VP - Clinical Services

• Linda Diehl Martz :   Project Dir. at Beardsworth, the Exec. Dir. - Data Management

FLEMINGTON, N.J., June 24 /PRNewswire/ -- [Beardsworth Consulting Group, Inc.] announces the appointments of Alison Martin, M.D. as the company's Scientific Advisor, Oncology and Robert W. Malone, M.D. as the company's Medical Director, Vaccines.

Dr. Alison Martin is one of oncology's respected research leaders with over 20 years of clinical research experience. She joins Beardsworth from the National Cancer Institute (NCI) where she was most recently Head of Genitourinary Cancers and Melanoma Therapeutics in the Clinical Investigations Branch of the Cancer Therapy Evaluation Program (CTEP). Dr. Martin was scientific co-chair along with Dr. Meenhard Herlyn of the 2007 NCI-Community-Oriented Strategic Action Plan for Melanoma Research. She has served as liaison to three of NCI's cooperative groups and been a senior investigator in the Investigational Drug Branch of CTEP. In addition to experience at NCI, Dr. Martin was a team leader in the Office of Oncology Drug Products at the U.S. Food and Drug Administration and has experience working with the biotechnology and pharmaceutical industries.

[Dr. Robert Wallace Malone (born 1959)] has extensive experience in viral and recombinant vaccines, biodefense, gene delivery and transfer, immunology, tissue and cell culture, and DNA vaccination in both the commercial and government market sectors. An internationally recognized scientist, Dr. Malone is known as one of the original inventors of "DNA Vaccination" holding numerous fundamental domestic & foreign patents in the fields of gene delivery, delivery formulations, and vaccines. His background includes over 25 years of experience in academia and industry, including both founding and working with a wide range of pharmaceutical and biotech companies. He has experience in federal contracting, working with NGO's in health related research and development as well as relationships with CDC, DOD and HHS. Dr. Malone is involved with 15 issued patents, has numerous publications and two book chapters in this field, and serves as editor-in-chief of the Journal of Immune Based Therapies and Vaccines.

"We are honored and excited to have Alison and Robert join the Beardsworth team," said Michael J. O'Brien, President and CEO, Beardsworth. He added, "the increasing demands of Oncology and Vaccine research, individually and together, place Beardsworth in an attractive position given our many years of experience in these two areas. Alison and Robert will provide valuable expertise and vision to the expanding clinical research needs of our growing client base."

As members of Beardsworth's team, Drs. Martin and Malone join other noted industry experts whose collective strategic scope and in-depth knowledge support Beardsworth's mission of delivering superior quality clinical services, on time and on budget.

Headquartered in Flemington, New Jersey, Beardsworth is a privately held contract research organization delivering research and business solutions for clinical research programs since 1986. Focused on complicated trials in complex therapeutic areas, Beardsworth's clinical team expertise, advanced technology platform, and "Investigator Express" process provide clients with a patient-centric approach to study management, patient recruitment and cost-effective solutions. Beardsworth is a WBENC-certified, woman-owned business and registrant with CCR.

• • • SOURCE Beardsworth Consulting Group, Inc.

READINGTON TWP. — Donna E. Beardsworth died on Monday, March 21, 2011, at her home. She was 54.

Born in Danbury, Conn. on Sept. 20, 1956, she was a daughter of Evelyn Johnson Beardsworth and Donald A. Beardsworth. She had resided in Readington Township for the past 25 years.

Ms. Beardsworth received her B.A. in chemistry and her M.A. in biology, both from Mount Holyoke College. She was the CEO of Beardsworth Consulting Group, Flemington, which conducts clinical trials for various pharmaceutical companies, with a focus on oncology.
She was a formerly a member of the Board of Directors of SAFE in Hunterdon; a member of the Drug Investigation Association; and a member of WEBANK.

Surviving are her father, Donald A. Beardsworth of Wellington, Fla.; a brother, Douglas Beardsworth of Woodbury, Conn.; and several nieces and nephews.

Services: Calling hours Friday, March 25, 3-5 p.m. and memorial service at 5 for family and friends in the Holcombe-Fisher Funeral Home, 147 Main St., Flemington. Interment is private.

Visit holcombefisher.com for further information or to send condolences.

Memorial contributions can be made to a cancer charity of the donor's choice or to Mount Holyoke College.

FLEMINGTON, N.J., March 23, 2011 /PRNewswire/ -- Donna E. Beardsworth, age 54, the Founder, President & CEO of the Contract Research Organization, Beardsworth Consulting Group, Inc., passed away unexpectedly early Sunday morning.

"We are shocked and greatly saddened by the passing of Donna. She was a dear friend who cared deeply about people and humanity. Donna was a visionary leader, a devoted clinician and a mentor to many within the Clinical Research Industry. The people with whom she worked over the years will deeply mourn her loss and miss her spirit. We extend our sympathies to her family and all of her friends," said Vincent F. DiBianca, a principal in the company.

The Board has appointed Michael O'Brien as the President & CEO. Mr. O'Brien, who has been with the company for nine years, previously served for the past four and a half years as President & CEO, until December, 2010. 

"Donna's vision for our company was to focus on complicated clinical trials in Oncology and other difficult therapeutic areas. Her goal was to make an impactful difference in healthcare. She was a true pioneer in the CRO industry, and we have all been inspired by her dedication and limitless spirit," said Mr. O'Brien. "Donna was very proud to be ushering in the 25th anniversary of Beardsworth this year, and the company is fully committed to continuing her legacy."

In recognition of her corporate stewardship and vision, Donna was honored with the Entrepreneur of the Year Award by the Hunterdon County Chamber of Commerce. Donna Beardsworth's high standards and steadfast commitment to quality and integrity are reflected in the company's recent successes and growth.

• • • SOURCE Beardsworth Consulting Group, Inc.